Target intelligence / Profile preview

Dietary inorganic phosphate

Molecular classification
Other
01

Overview

Dietary inorganic phosphate refers to the inorganic phosphate ions (Pi) present in foods—especially as additives in processed foods—which are a critical dietary source of phosphate. Inorganic phosphate is readily absorbed in the intestine, much more so than organic forms present in natural foods. Phosphate is essential for the formation of bones and teeth (as hydroxyapatite), energy metabolism (via ATP), structure of DNA/RNA and cell membranes, cellular signaling, and pH buffering. However, excessive intake—particularly from food additives—can disrupt phosphate and calcium homeostasis, especially in individuals with impaired renal function, leading to complications such as bone disease and increased cardiovascular risk. In clinical practice, phosphate is monitored as a laboratory value, and excess phosphate is reduced using dietary restriction and phosphate binder medications in at-risk populations such as CKD patients.

Other names
Inorganic phosphatePiPhosphate additiveDietary phosphatePhosphate ionDietary Pi
02

Mechanism of action

Phosphate binders reduce intestinal absorption of dietary phosphate by binding to it in the gut. Some drugs act by modifying renal phosphate handling (e.g., by regulating parathyroid hormone or FGF23 signaling).

03

Biological functions

Energy metabolism/ATP productionComponent of DNA/RNA synthesisBone and teeth mineralizationCellular signaling (as phosphate group in phosphorylation)pH buffering in blood and tissuesEnzyme activation/regulationCell membrane structure (as phospholipids)
04

Disease associations

Chronic kidney disease (CKD) and complications of hyperphosphatemiaCardiovascular disease (vascular calcification)Bone diseases (osteomalacia, rickets, osteoporosis)HyperparathyroidismHypophosphatemiaCognitive and neurological effects (in severe imbalances)
05

Safety considerations

Overconsumption leads to hyperphosphatemiaIncreased risk of vascular calcification and cardiovascular diseaseNegative effects on bone health in chronic kidney diseaseOften "hidden" in processed foods as additives with high bioavailability
06

Interacting drugs

Phosphate binders (e.g., sevelamer, calcium acetate)

2 more in the full profile.

07

Biomarkers

Serum phosphate levelSerum calciumParathyroid hormone (PTH)FGF23Vitamin D

Beyond the preview

Go deeper on Dietary inorganic phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary inorganic phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call